The LiBBY trial found that a purified THC and CBD oil lowered agitation in 120 hospice-eligible people with late-stage dementia. Researchers still need larger Phase 3 trials, dosing work, and safety follow-up before spouses and partners can use it in routine care.
LiBBY means Life's End Benefits of cannaBidiol and tetrahYdrocannabinol. Agitation here means persistent restlessness, shouting, resisting care, or physical unease. The study focused on home-based hospice-eligible patients with Alzheimer's or other dementia and significant agitation.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What did the trial test
- How much did agitation improve
- What safety signals matter for families
- Can spouses use dispensary cannabis instead
- What researchers still need to learn
What did the trial test
The Phase 2 trial was multicenter, randomized, double-blind, and placebo-controlled across 10 U.S. sites with home visits. It enrolled hospice-eligible adults with Alzheimer's or other dementia and significant agitation.
The drug was T2:C100, a purified oral digestible oil with 2 mg THC and 100 mg CBD twice daily after titration. Full dosing ran in weeks 2 through 12. The formula was made under medical supervision for the study. Researchers say the result does not transfer to store or dispensary products.
How much did agitation improve
Treated participants had a 6.27-point greater drop in Cohen-Mansfield Agitation Inventory scores than placebo at 2 weeks. The Cohen-Mansfield scale measures frequency of agitated actions such as pacing, yelling, and grabbing. Separation lasted through 12 weeks.
The Alzheimer's Association reports nearly 9 in 10 treated participants improved, with 87.2% improved at week 12 versus 23.6% on placebo read the Association summary. Improvement reached 83.9% at week 2 versus 30.5% on placebo. For a spouse, that pattern means faster calm around daily care, sleep disruption, and evening restlessness. It does not mean clearer memory, restored speech, or independent function.
What safety signals matter for families
Overall adverse events were similar between groups in this end-of-life group. Serious events were higher with active treatment, at 23.3% versus 11.9%. NeurologyLive reports the increase was driven by serious infections, 11.7% versus 1.7%, with more deaths on active therapy, 13.1% versus 5.1% see the trial safety report.
These numbers reflect very ill hospice-eligible participants, not healthier early-stage patients. Spouses should weigh calm against infection risk, sedation, falls, and drug interactions. Report fever, cough, reduced fluid intake, new confusion, unusual sleepiness, or falls to the hospice nurse promptly.
Can spouses use dispensary cannabis instead
No. The LiBBY Study team states the findings apply only to the specific purified formulation and supervised dosing system studied review the study results.
Dispensary and over-the-counter products vary in THC dose, CBD dose, contaminants, and labeling accuracy. That difference matters for late-stage dementia because small THC changes can alter sedation and balance. Food, liver changes, and other medicines also change cannabis effects.
- Do not start, stop, or swap a cannabis product on your own
- Bring the full medicine, supplement, and alcohol list to hospice care
- Track agitation triggers, timing, sleep, pain, hunger, and toileting needs
- Ask the hospice team about non-drug calming steps first
What researchers still need to learn
This was a 120-person Phase 2 topline presentation, not a final treatment standard. Next work includes larger Phase 3 trials and peer-reviewed publication.
Other needs are optimal dose, treatment length, risk factors, and which hospice-eligible patients benefit most. Funding included NIH National Institute on Aging grant R01AG068324 and the Alzheimer's Association, through investigators at Medical University of South Carolina, Georgetown, and USC ATRI. For now, spouses can keep a short daily note of agitation episodes, pain signs, sleep, and what helped, then share it at each hospice visit.
You Might Also Like
- p-tau217 Findings a Decade Before Alzheimer’s Symptoms in 2026: What Researchers Still Need to Learn for Spouses and Partners
- AAIC 2026 p-tau217 Alzheimer’s Risk Prediction Research: What Researchers Still Need to Learn for Spouses and Partners
- Dementia With Multiple Etiologies in the 2026 NIA Report: Who Was Studied and Who Was Not for Spouses and Partners





